Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyasu Yamamoto

Showing results (51-60 of 170) with videos related to

Pageof 17
Sort By:
Clinical Transplantation|July 20, 2006
Secondary focal segmental glomerulosclerosis following kidney transplantation in a patient with type I diabetes mellitusIzumi Yamamoto, Hiroyasu Yamamoto, Jun Mitome, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2003
Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patientsHiroyasu Yamamoto, Naohiko Katoh, Hiroshi Takeyama, et al.
Clinical Nephrology|December 22, 2011
Clinicopathological impacts of activated transcription factor c-Jun in peritubular capillary endothelial cells in chronic antibodymediated rejection after kidney transplantationAkimitsu Kobayashi, Takamune Takahashi, Shigeru Horita, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2010
Anxiety for the influenza of the patient with dialysis: choice of the HD/PD combination therapyKeitaro Yokoyama, Nanae Matsuo, Yasuo Kimura, et al.
Nephron|August 7, 2019
Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney DiseaseTadao Akizawa, Iain C Macdougall, Jeffrey S Berns, et al.
Clinical and Experimental Nephrology|April 24, 2023
Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trialsHiroyasu Yamamoto, Takashi Yamada, Ken Miyazaki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2006
Successful living-related kidney transplantation in hereditary renal hypouricaemiaIzumi Yamamoto, Hiroyasu Yamamoto, Kimiyoshi Ichida, et al.
Metabolism: Clinical and Experimental|November 25, 2004
Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroidsSoji Kasayama, Mari Fujita, Kayoko Goya, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 6, 2007
Is encapsulating peritoneal sclerosis a threatening issue in continuous ambulatory peritoneal dialysis? The Japanese experienceMasaaki Nakayama, Masato Ikeda, Naohiko Katoh, et al.
Kidney International|August 30, 2008
Middle molecular uremic substances retention itself might influence the bioincompatibility of PD solutionKeitaro Yokoyama, Nanae Matsuo, Hiraku Yoshida, et al.
Pageof 17

Showing results (51-60 of 170) with videos related to

Sort By:
Pageof 17
Clinical Transplantation|July 20, 2006
Secondary focal segmental glomerulosclerosis following kidney transplantation in a patient with type I diabetes mellitusIzumi Yamamoto, Hiroyasu Yamamoto, Jun Mitome, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2003
Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patientsHiroyasu Yamamoto, Naohiko Katoh, Hiroshi Takeyama, et al.
Clinical Nephrology|December 22, 2011
Clinicopathological impacts of activated transcription factor c-Jun in peritubular capillary endothelial cells in chronic antibodymediated rejection after kidney transplantationAkimitsu Kobayashi, Takamune Takahashi, Shigeru Horita, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2010
Anxiety for the influenza of the patient with dialysis: choice of the HD/PD combination therapyKeitaro Yokoyama, Nanae Matsuo, Yasuo Kimura, et al.
Nephron|August 7, 2019
Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney DiseaseTadao Akizawa, Iain C Macdougall, Jeffrey S Berns, et al.
Clinical and Experimental Nephrology|April 24, 2023
Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trialsHiroyasu Yamamoto, Takashi Yamada, Ken Miyazaki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2006
Successful living-related kidney transplantation in hereditary renal hypouricaemiaIzumi Yamamoto, Hiroyasu Yamamoto, Kimiyoshi Ichida, et al.
Metabolism: Clinical and Experimental|November 25, 2004
Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroidsSoji Kasayama, Mari Fujita, Kayoko Goya, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 6, 2007
Is encapsulating peritoneal sclerosis a threatening issue in continuous ambulatory peritoneal dialysis? The Japanese experienceMasaaki Nakayama, Masato Ikeda, Naohiko Katoh, et al.
Kidney International|August 30, 2008
Middle molecular uremic substances retention itself might influence the bioincompatibility of PD solutionKeitaro Yokoyama, Nanae Matsuo, Hiraku Yoshida, et al.
Pageof 17